Literature DB >> 393633

Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.

H A Verbrugh, W C van Dijk, M E van Erne, R Peters, P K Peterson, J Verhoef.   

Abstract

The role of the third component of human complement (C3) in the opsonization of bacteria in nonimmune human sera was evaluated. The amount of C3 that becomes attached to the surface of bacteria upon incubation in serum was measured in a quantitative fluorescent immunoassay using fluorescein-conjugated monospecific antiserum to human C3. The intensity of the fluorescence from opsonized bacteria was found to be directly proportional to the absolute amount of C3 fixed, and this enabled the detection of as few as 300 molecules of bound C3 per bacterium. In normal serum the rate of C3 fixation was closely correlated with an increase in opsonization of the bacteria for human PMNs. Both C3 fixation and opsonization were maximal after 15 min of incubation. C3 fixation was also observed, albeit at a significantly slower rate, in human serum with a nonfunctional classical pathway but an intact alternative complement pathway and in serum deficient in immunoglobulins. Again, the kinetics of C3 fixation correlated with bacterial opsonization. Using a total of 21 strains of several bacterial species, including Staphylococcus aureus and Escherichia coli, encapsulation of bacteria was found to interfere with the process of C3 fixation in normal human serum, rendering these organisms resistant to subsequent phagocytosis by human polymorphonuclear leukocytes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 393633      PMCID: PMC414690          DOI: 10.1128/iai.26.3.808-814.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.

Authors:  R D Schreiber; M K Pangburn; P H Lesavre; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

2.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

3.  Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity.

Authors:  P Stevens; S N Huang; W D Welch; L S Young
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

4.  Serum opsonization of salmonella in sickle cell anemia.

Authors:  W L Hand; N L King
Journal:  Am J Med       Date:  1978-03       Impact factor: 4.965

5.  Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.

Authors:  J Verhoef; P Peterson; Y Kim; L D Sabath; P G Quie
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

Review 6.  Microbial surfaces in relation to pathogenicity.

Authors:  H Smith
Journal:  Bacteriol Rev       Date:  1977-06

7.  Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.

Authors:  H A Verbrugh; W C Van Dijk; R Peters; M E Van Der Tol; P K Peterson; J Verhoef
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

8.  Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis.

Authors:  W C Van Dijk; H A Verbrugh; R Peters; M E Van Der Tol; P K Peterson; J Verhoef
Journal:  J Med Microbiol       Date:  1979-02       Impact factor: 2.472

9.  Quantitative fluorescent immunoassay of antibodies to, and surface antigens of, Actinomyces viscosus.

Authors:  T P Gillis; J J Thompson
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

10.  Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.

Authors:  P K Peterson; B J Wilkinson; Y Kim; D Schmeling; P G Quie
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

View more
  21 in total

1.  Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface.

Authors:  G Raponi; N Keller; B P Overbeek; M Rozenberg-Arska; K P van Kessel; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

2.  Local application of omega-conotoxin GVIA to sympathetic nerve terminals in the guinea-pig isolated vas deferens.

Authors:  J A Brock; T C Cunnane; J Ziogas
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

3.  Influence of nutrient limitation and low pH on serogroup B Neisseria meningitidis capsular polysaccharide levels: correlation with virulence for mice.

Authors:  L Masson; B E Holbein
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

4.  Inhibition of neutrophil function by fluid phase C3b of complement.

Authors:  J D Ogle; C K Ogle; J W Alexander
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

5.  Testing phagocytic cell function.

Authors:  J Verhoef; F A Waldvogel
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

6.  Bactericidal and opsonizing effects of normal serum on mutant strains of Salmonella typhimurium.

Authors:  M F Shaio; H Rowland
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.

Authors:  F Namavar; J A Kaan; A M Verweij-van Vught; W A Vel; M Bal; A D Kester; D M MacLaren
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

8.  Differential complement resistance mediates virulence of Haemophilus influenzae type b.

Authors:  A Sutton; R Schneerson; S Kendall-Morris; J B Robbins
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

9.  The role of complement opsonization in interactions between F. tularensis subsp. novicida and human neutrophils.

Authors:  Jason H Barker; Ramona L McCaffrey; Nicki K Baman; Lee-Ann H Allen; Jerrold P Weiss; William M Nauseef
Journal:  Microbes Infect       Date:  2009-05-04       Impact factor: 2.700

10.  Clindamycin enhances opsonization of Staphylococcus aureus.

Authors:  D Milatovic; I Braveny; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.